Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
22,477,555
-
Share change
-
+3,661,204
-
Total reported value
-
$213,589,026
-
Put/Call ratio
-
78%
-
Price per share
-
$9.50
-
Number of holders
-
103
-
Value change
-
+$39,996,206
-
Number of buys
-
70
-
Number of sells
-
41
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2014
As of 31 Mar 2014,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,477,555 shares.
The largest 10 holders included
LANSDOWNE PARTNERS LIMITED PARTNERSHIP, FMR LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, SAC Capital Advisors LP, ROYCE & ASSOCIATES LLC, BROOKSIDE CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT CO LLP, and Visium Asset Management, LP.
This page lists
103
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.